Back
8
Day Range
$21.51
$27.10
52-Week Range
$21.51
$27.10
Volume
2,818
50D / 200D Avg
$21.51
/
$23.37
Prev Close
$21.51
Price History
Financial Trends
Peer Comparison
vs Industrials sector median (893 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.6 | 14.4 |
| P/B | 0.1 | 1.9 |
| ROE % | 16.7 | 11.4 |
| Net Margin % | 11.4 | 6.5 |
| Rev Growth 5Y % | 13.4 | 8.4 |
| D/E | 1.0 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$2.22
$2.19 – $2.26
|
1.2 B | 1 |
| FY2027 |
$2.33
$2.29 – $2.37
|
1.2 B | 1 |
| FY2026 |
$2.43
$2.39 – $2.47
|
1.2 B | 1 |
Key Takeaways
Revenue grew 13.44% annually over 5 years — strong growth
Earnings grew 24.62% over the past year
ROE of 16.73% — decent returns on equity
P/E of 0.64 — trading at a low valuation
PEG of 0.26 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 21.14%
Growth
Revenue Growth (5Y)
13.44%
Revenue (1Y)-7.70%
Earnings (1Y)24.62%
FCF Growth (3Y)N/A
Quality
Return on Equity
16.73%
ROIC10.33%
Net Margin11.38%
Op. Margin19.94%
Safety
Debt / Equity
0.95
Current Ratio1.77
Interest Coverage1.84
Valuation
P/E Ratio
0.64
P/B Ratio0.10
EV/EBITDA1.37
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -7.70% | Revenue Growth (3Y) | 0.07% |
| Earnings Growth (1Y) | 24.62% | Earnings Growth (3Y) | 17.02% |
| Revenue Growth (5Y) | 13.44% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 12.49B | Net Income (TTM) | 1.42B |
| ROE | 16.73% | ROA | 5.62% |
| Gross Margin | 99.98% | Operating Margin | 19.94% |
| Net Margin | 11.38% | Free Cash Flow (TTM) | N/A |
| ROIC | 10.33% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.95 | Current Ratio | 1.77 |
| Interest Coverage | 1.84 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 0.64 | P/B Ratio | 0.10 |
| P/S Ratio | 0.07 | PEG Ratio | 0.26 |
| EV/EBITDA | 1.37 | Dividend Yield | 0.06% |
| Market Cap | 914.73M | Enterprise Value | 3.42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 12.49B | 13.53B | 12.47B | 11.43B | 7.54B |
| Net Income | 1.42B | 1.14B | 1.04B | 397.31M | -106.56M |
| EPS (Diluted) | 33.47 | 26.80 | 24.40 | 9.34 | -2.51 |
| Gross Profit | 12.48B | 13.02B | 11.45B | 10.48B | 5.31B |
| Operating Income | 2.49B | 2.32B | 2.44B | 3.85B | 1.00B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 25.31B | 25.26B | 23.50B | 21.75B | 19.12B |
| Total Liabilities | 14.07B | 16.09B | 15.60B | 14.80B | 14.69B |
| Shareholders' Equity | 9.25B | 7.74B | 6.68B | 5.72B | 4.62B |
| Total Debt | 8.82B | 9.98B | 10.08B | 10.18B | 10.42B |
| Cash & Equivalents | 6.31B | 5.98B | 4.79B | 4.85B | 3.42B |
| Current Assets | 9.46B | 9.79B | 9.46B | 8.73B | 6.46B |
| Current Liabilities | 5.36B | 6.54B | 6.03B | 4.42B | 4.26B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#582 of 670
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026